Press release
Acute Coronary Syndrome Market Set for Steady Growth to USD 14.70 Billion by 2031, Led by North America's 42% Market Share | DataM Intelligence
Acute Coronary Syndrome Market
Market growth is driven by the rising prevalence of cardiovascular diseases, increasing incidence of acute myocardial infarction and unstable angina, and growing adoption of antiplatelet and anticoagulant therapies. Advancements in percutaneous coronary interventions (PCI), expanding use of novel oral anticoagulants, rising investments in cardiovascular R&D, and increased regulatory approvals for next-generation stents and imaging diagnostics are further accelerating market expansion.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/acute-coronary-syndrome-market?ram
United States: Key Industry Developments
✅ November 2025: Janssen Research & Development advanced its Phase III PCSK9 inhibitor for Acute Coronary Syndrome (ACS), showing improved lipid-lowering efficacy in post-ACS patients, targeting residual cardiovascular risk reduction.
✅ September 2025: The Asia Pacific ACS market projected growth to USD 2.64 billion, driven by China's investments in cardiovascular research and Japan's precision medicine initiatives for ACS treatment.
✅ August 2025: Over five active ACS pipeline assets, including Factor XIa inhibitors from Hyloris Pharmaceuticals, focusing on antithrombotic therapies to prevent recurrent events.
Asia Pacific / Japan: Key Industry Developments
✅ November 2025: Japan advanced precision medicine for ACS via extensive healthcare infrastructure, emphasizing personalized treatment protocols amid rising cardiovascular cases.
✅ October 2025: China allocated substantial funding for ACS patient outreach and research programs, boosting early intervention as part of national health strategies.
✅ September 2025: Asia Pacific cath-lab infrastructure expanded rapidly in urban areas, with telecardiology support enhancing ACS emergency care access in emerging markets like India.
Key Mergers and Acquisitions:
✅ Bristol Myers Squibb enhanced its cardiovascular portfolio through the acquisition of Kiniksa Pharmaceuticals, advancing therapies for inflammatory conditions linked to Acute Coronary Syndrome.
✅ AstraZeneca partnered with Ionis Pharmaceuticals to develop eplontersen, targeting proteins involved in ACS-related cardiovascular events.
✅ Leading ACS market players pursued strategic mergers to broaden treatment portfolios and reinforce dominance in acute cardiovascular care segments.
Market Segmentation Analysis:
-By Type: NSTEMI Leads with Highest Incidence
Non-ST-elevation myocardial infarction (NSTEMI) holds the largest share at 50%, common in partial blockages causing ongoing chest pain without full infarction.
ST-elevation myocardial infarction (STEMI) captures 35%, marked by complete artery blockage needing urgent reperfusion.
Unstable angina accounts for 15%, involving reduced blood flow without heart damage, often a precursor to infarction.
-By Drugs: Antithrombotics Dominate for Clot Prevention
Antithrombotic drugs lead at 60%, including antiplatelets and anticoagulants essential for preventing thrombus formation in ACS events.
Statin drugs follow at 25%, lowering cholesterol to stabilize plaques and reduce recurrence risk.
Antihypertensive drugs take 15%, controlling blood pressure to ease cardiac strain post-ACS.
-By End-User: Hospitals Command Acute Care
Hospitals hold the top share at 65%, central for emergency interventions, catheterization, and inpatient monitoring in ACS crises.
Specialty clinics capture 25%, focusing on cardiology follow-ups and risk management.
Others, including ambulatory centers, account for 10%, supporting outpatient rehab and diagnostics.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=acute-coronary-syndrome-market?ram
Why is the Acute Coronary Syndrome Market Growing?
The rapid expansion of the Acute Coronary Syndrome (ACS) market in 2026 stems from rising cardiovascular disease burdens and healthcare innovations.
-Rising Prevalence of Risk Factors
Increasing incidences of obesity, diabetes, hypertension, and smoking drive ACS cases, particularly among aging populations worldwide. The global geriatric demographic shift amplifies demand for ACS diagnostics and treatments. Lifestyle-associated disorders like high cholesterol further elevate the need for interventions.
-Technological and Therapeutic Advances
Innovations in antiplatelet therapies, catheter-based procedures, and personalized medicine enhance treatment efficacy and patient outcomes. Novel biologics, thrombolytics, and minimally invasive options expand market opportunities. Improved diagnostic technologies enable earlier detection, boosting overall market dynamics.
-Healthcare Infrastructure and Awareness
Enhanced healthcare spending and infrastructure in emerging markets improve ACS care access. Growing public awareness of heart health promotes timely interventions. Regional investments, especially in Asia-Pacific, accelerate commercialization of ACS therapies.
Regional Insights:
-North America leads the Acute Coronary Syndrome (ACS) market with the largest share, accounting for approximately 42% of the global market in recent assessments, driven by advanced healthcare infrastructure, high prevalence of cardiovascular risk factors like obesity and diabetes, and widespread adoption of innovative diagnostics and therapies such as PCI and novel anticoagulants.
-Europe follows closely with around 32% market share, supported by strong public health systems, early detection programs, and research collaborations that enhance treatment access across countries like Germany and the UK.
-Asia Pacific holds about 18% of the market, experiencing the fastest growth due to rising healthcare investments, urbanization-induced lifestyle risks, and expanding cardiac care infrastructure in nations like China and India.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/acute-coronary-syndrome-market?ram
Key Players:
Teva Pharmaceuticals | Dr. Reddy's Laboratories | Boehringer Ingelheim | Johnson & Johnson | Merck | Novartis | Amgen Inc. | AbbVie Inc. | AstraZeneca PLC | GlaxoSmithKline Plc
Key Highlights (Top 5 Key Players) for Acute Coronary Syndrome Market:
-Teva Pharmaceuticals develops generic antiplatelet agents and anticoagulants, enabling affordable access to essential therapies like clopidogrel for preventing thrombotic events in ACS patients.
-Boehringer Ingelheim advances anti-thrombotic treatments such as rivaroxaban-based combinations, focusing on reducing recurrent ischemic risks post-ACS through pivotal trials like COMPASS.
-Johnson & Johnson (via Janssen) pioneered blockbuster anticoagulants like Xarelto (rivaroxaban), targeting factor Xa inhibition to lower stroke and mortality rates in high-risk ACS populations.
-AstraZeneca PLC drives innovation with Brilinta (ticagrelor), a P2Y12 inhibitor proven in PLATO trials to improve outcomes in ACS by enhancing platelet inhibition speed and reversibility.
-Novartis supports ACS management via lipid-lowering therapies like Inclisiran, an siRNA-based PCSK9 inhibitor that sustains LDL reductions to mitigate long-term cardiovascular complications.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Coronary Syndrome Market Set for Steady Growth to USD 14.70 Billion by 2031, Led by North America's 42% Market Share | DataM Intelligence here
News-ID: 4341800 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Intravascular Catheters Market to hit US$ 4.33 Billion by 2031 | M …
Leander, Texas and Tokyo, Japan - Jan.09.2026
As per DataM intelligence research report" The Global Intravascular Catheters Market reached US$ 7.78 billion in 2023 and is expected to reach US$ 14.44 billion by 2031, growing at a CAGR of 8.1% during the forecast period 2024-2031." Rising cardiovascular procedures and minimally invasive care are driving demand.
Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/intravascular-catheters-market?prasad
United States Recent Industry Developments:
✅ In…
Chronic Disease Management Market to Reach US$ 14.6 Billion by 2031 at 11.4% CAG …
The Global Chronic Disease Management Market reached US$ 4.8 billion in 2022 and is expected to reach US$ 14.6 billion by 2031, growing at a CAGR of 11.4% during the forecast period 2024-2031. This growth is driven by the rising prevalence of chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders, along with increasing adoption of digital health and remote patient monitoring solutions.
Chronic disease management solutions support continuous monitoring,…
Blood and Fluid Warmer Market to Grow at 9.2% CAGR through 2031, Driven by Risin …
According to DataM Intelligence, the global Blood and Fluid Warmer market is expected to grow at a CAGR of 9.2% during the forecast period 2024-2031. This growth is propelled by increasing number of surgical procedures worldwide, rising emphasis on preventing perioperative hypothermia, growing adoption of intravenous and surface warming systems in hospitals and acute care settings, expanding use in newborn care and homecare, advancements in portable and smart warming devices,…
United States Radiation Dose Management Market Size, Growth Divers, Industry ins …
Leander, Texas and Tokyo, Japan - Jan.09.2026
As per DataM intelligence research report" Radiation Dose Management Market is expected to grow at a high CAGR during the forecast period 2024-2031." Patient safety and regulatory compliance are boosting radiation monitoring solutions.
Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/radiation-dose-management-market?prasad
United States Recent Industry Developments:
✅ In December 2025, Virtual Phantoms launched "VirtualDose DX," a new simulation software The tool models organ…
More Releases for ACS
BOC Sciences to Showcase Innovative Solutions at ACS Fall 2025
BOC Sciences will present at ACS Fall 2025 (Booth #2230), one of the largest scientific conferences held by the American Chemical Society (ACS).
As the daunting challenges the world has been facing continue to bring an impact to the biopharmaceutical industry, this year's hybrid event, onsite in Washington, DC and virtually on 17-21 August, presents one more opportunity for BOC Sciences to demonstrate its world class capabilities for helping to make…
ACS RPL Australia - Avail Professional Services by CDRAustralia.Org
Preparing a Recognition of Prior Learning (RPL) report is essential for applicants who want their immigration to Australia but do not have an ICT qualification or other relevant tertiary qualification. Such candidates need to demonstrate that they have acquired the equivalent level of knowledge and experience in the IT industry. The Australian Computer Society (ACS) is the regulating body that provides the RPL assessment pathway for applicants who have sufficient…
ACS Bathrooms Fortitude Valley
ACS Designer Bathrooms, we are committed to excellence, and this commitment is evident in every single product that we sell. We offer a broad range of high-quality bath and kitchen products that will elevate the look of your home, giving it elegance and a sense of luxury in every room.
ACS Designer Bathrooms, we are committed to excellence, and this commitment is evident in every single product that we sell. We…
Specialty Trade Contractors Market Size, Share, Growth Analysis 2018-2023 with T …
The specialty construction contractor industry includes establishments involved in performing specific activities such as pouring concrete, site preparation, plumbing, painting and electrical work related to construction of buildings. These establishments are not responsible for an entire construction project but perform activities such as new work, additions, alterations, maintenance and repairs on a contractual basis for the main builder or owner.
Get Sample Copy of this Report @ https://www.orianresearch.com/request-sample/681923 .
Specialty…
Air Conditioning Systems Market - Split ACs Witness Highest Demand
The vendor landscape of the global air conditioning systems market is speckled with large and established companies such as Gree Electric Appliances, Inc., Daikin Industries Ltd., and Carrier Corporation; emerging players such as Panasonic Corporation, Mitsubishi Corporation, and The Midea Group; and promising vendors such as LG Electronics, Haier Electronics Group Co., Ltd., and Hitachi Ltd. Each of these players have been striving to strengthen their position in the air…
Graphene Oxide Market 2017- Angstron Materials, Graphenea,Garmor,ACS Material
The Global Graphene Oxide Market 2017 Industry Research Report focused on major manufacturers, regions, type as well as application of the Graphene Oxide industry. “””Graphene, a multi or single layer sheet of graphite, is the strongest material available, as well as being highly transparent, flexible, and the best conductor of heat and electricity. Great effort is devoted to developing an effective yet inexpensive way to produce graphene materials in industrial…
